bennn
2021-09-14T02:40:25+00:00
cdc发的一个报告是第一个大规模实锤辉瑞的长期抗重症效果下降的数据
VE against COVID-19 hospitalization during March 11August 15, 2021, was higher for the Moderna vaccine (VE = 93%) than for the Pfizer-BioNTech vaccine (VE = 88%) (p = 0.011); VE for both mRNA vaccines was higher than that for the Janssen vaccine (VE = 71%) (all p<0.001) (Table 2). VE for the Moderna vaccine was 93% at 14120 days (median = 66 days) after receipt of the second vaccine dose and 92% at >120 days (median = 141 days) (p = 1.000). VE for the Pfizer-BioNTech vaccine was 91% at 14120 days (median = 69 days) after receipt of the second vaccine dose but declined significantly to 77% at >120 days (median = 143 days) (p<0.001).
辉瑞120天(中位数69天)内抗重症率是92%，120天以上(中位数143)抗重症率就只有77%了
莫得纳表现依旧良好
[url]https://www.cdc.gov/mmwr/volumes/70/wr/mm7038e1.htm?s_cid=mm7038e1_w[/url]
辉瑞拉中拉被实锤的话 复兴根本不可能在国内获批
逻辑已经讲不下去了？
VE against COVID-19 hospitalization during March 11August 15, 2021, was higher for the Moderna vaccine (VE = 93%) than for the Pfizer-BioNTech vaccine (VE = 88%) (p = 0.011); VE for both mRNA vaccines was higher than that for the Janssen vaccine (VE = 71%) (all p<0.001) (Table 2). VE for the Moderna vaccine was 93% at 14120 days (median = 66 days) after receipt of the second vaccine dose and 92% at >120 days (median = 141 days) (p = 1.000). VE for the Pfizer-BioNTech vaccine was 91% at 14120 days (median = 69 days) after receipt of the second vaccine dose but declined significantly to 77% at >120 days (median = 143 days) (p<0.001).
辉瑞120天(中位数69天)内抗重症率是92%，120天以上(中位数143)抗重症率就只有77%了
莫得纳表现依旧良好
[url]https://www.cdc.gov/mmwr/volumes/70/wr/mm7038e1.htm?s_cid=mm7038e1_w[/url]
辉瑞拉中拉被实锤的话 复兴根本不可能在国内获批
逻辑已经讲不下去了？